153 related articles for article (PubMed ID: 20190784)
1. Type 1 diabetes.
Burn P
Nat Rev Drug Discov; 2010 Mar; 9(3):187-8. PubMed ID: 20190784
[No Abstract] [Full Text] [Related]
2. Hypoglycaemia: costs, insulins and prevention.
Holt RI
Diabet Med; 2016 Apr; 33(4):419-20. PubMed ID: 26995756
[No Abstract] [Full Text] [Related]
3. American Diabetes Association--69th Scientific sessions. Hyperinsulinism, insulin resistance and the treatment of diabetes: Part 2.
Kouremenou C
IDrugs; 2009 Aug; 12(8):465-6. PubMed ID: 19629874
[No Abstract] [Full Text] [Related]
4. Intensive insulin therapy is good value, say researchers.
Am J Health Syst Pharm; 1997 Jan; 54(2):116. PubMed ID: 9117799
[No Abstract] [Full Text] [Related]
5. Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group.
Matthews JB; Staeva TP; Bernstein PL; Peakman M; von Herrath M;
Clin Exp Immunol; 2010 May; 160(2):176-84. PubMed ID: 20629979
[TBL] [Abstract][Full Text] [Related]
6. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Bolinder J
Diabetes Technol Ther; 2017 Feb; 19(S1):S42-S58. PubMed ID: 28192016
[No Abstract] [Full Text] [Related]
7. New Medications for the Treatment of Diabetes.
Garg SK; Giordano D; Gallo T; Shah VN
Diabetes Technol Ther; 2017 Feb; 19(S1):S128-S140. PubMed ID: 28192022
[No Abstract] [Full Text] [Related]
8. Emergence of promising therapies in diabetes mellitus.
Akkati S; Sam KG; Tungha G
J Clin Pharmacol; 2011 Jun; 51(6):796-804. PubMed ID: 20705952
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies.
Fitchett D
Can J Diabetes; 2015 Dec; 39 Suppl 5():S176-82. PubMed ID: 26654861
[No Abstract] [Full Text] [Related]
10. Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers.
Zinman B
Diabetologia; 1997 Jul; 40 Suppl 2():S88-90. PubMed ID: 9248707
[No Abstract] [Full Text] [Related]
11. Emerging treatments for the prevention of type 1 diabetes.
Raskin P; Mohan A
Expert Opin Emerg Drugs; 2010 Jun; 15(2):225-36. PubMed ID: 20384544
[TBL] [Abstract][Full Text] [Related]
12. Combination therapies for type 1 diabetes: why not now?
von Herrath M
Immunotherapy; 2010 May; 2(3):289-91. PubMed ID: 20635894
[No Abstract] [Full Text] [Related]
13. Diabetes mellitus in adults.
Saltman RJ; Orland MJ; Levin ME
Compr Ther; 1988 Sep; 14(9):55-64. PubMed ID: 3064962
[No Abstract] [Full Text] [Related]
14. Hypoglycaemia, analogue insulins; prescribing cost or quality of life?
Hitman GA
Diabet Med; 2012 Mar; 29(3):289. PubMed ID: 22364579
[No Abstract] [Full Text] [Related]
15. Whither inhaled insulin?
Young B
Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):413. PubMed ID: 16932324
[No Abstract] [Full Text] [Related]
16. Insulin at 100: time for action on costs.
The Lancet Diabetes Endocrinology
Lancet Diabetes Endocrinol; 2021 Mar; 9(3):127. PubMed ID: 33607037
[No Abstract] [Full Text] [Related]
17. On the road to the insulin centenary.
Beran D; Basey M; Wirtz V; Kaplan W; Atkinson M; Yudkin JS
Lancet; 2012 Nov; 380(9854):1648. PubMed ID: 23141616
[No Abstract] [Full Text] [Related]
18. Long-acting insulin analogs versus human insulins.
Garg SK; Naik RG
Diabetes Technol Ther; 2008 Oct; 10(5):331-2. PubMed ID: 18715208
[No Abstract] [Full Text] [Related]
19. Basal insulin analogues in the management of diabetes mellitus: What progress have we made?
Owens DR; Matfin G; Monnier L
Diabetes Metab Res Rev; 2014 Feb; 30(2):104-19. PubMed ID: 24026961
[TBL] [Abstract][Full Text] [Related]
20. Prolactin: An Effective Partner for Anti-CD3 in Treating Type 1 Diabetes.
Xiao X
Endocrinology; 2016 Jan; 157(1):39-41. PubMed ID: 26717470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
